| NDC Code | 43742-1383-1 |
|---|
| Package Description | 30 mL in 1 BOTTLE, DROPPER (43742-1383-1) |
|---|
| Product NDC | 43742-1383 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Viril |
|---|
| Non-Proprietary Name | Benzoicum Acidum, Caladium Seguinum, Chimaphila Umbellata, Clematis Erecta, Rhododendron, Sabal Serrulata, Natrum Muriaticum, Cortisone Aceticum, Hypothalamus Suis, Prostate (suis), Testosterone, Agnus Castus, Aurum Metallicum, Bryonia (alba), Conium Maculatum, Lycopodium Clavatum, Selenium Metallicum, Sepia, Thuja Occidentalis, Kali Arsenicosum, Bufo Rana |
|---|
| Dosage Form | LIQUID |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20180905 |
|---|
| End Marketing Date | 20290228 |
|---|
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
|---|
| Manufacturer | Deseret Biologicals, Inc. |
|---|
| Substance Name | BENZOIC ACID; DIEFFENBACHIA SEGUINE; CHIMAPHILA UMBELLATA; CLEMATIS RECTA FLOWERING TOP; RHODODENDRON AUREUM LEAF; SAW PALMETTO; SODIUM CHLORIDE; CORTISONE ACETATE; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PROSTATE; TESTOSTERONE; CHASTE TREE; GOLD; BRYONIA ALBA ROOT; CONIUM MACULATUM FLOWERING TOP; LYCOPODIUM CLAVATUM SPORE; SELENIUM; SEPIA OFFICINALIS JUICE; THUJA OCCIDENTALIS LEAFY TWIG; POTASSIUM ARSENITE ANHYDROUS; BUFO BUFO CUTANEOUS GLAND |
|---|
| Strength | 6; 6; 6; 6; 6; 6; 6; 8; 8; 8; 8; 12; 12; 12; 12; 12; 12; 12; 12; 15; 16 |
|---|
| Strength Unit | [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
|---|
| Pharmacy Classes | Allergens [CS], Ammonium Ion Binding Activity [MoA], Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Histamine Release [PE], Nitrogen Binding Agent [EPC], Standardized Chemical Allergen [EPC] |
|---|
| DEA Schedule | CIII |
|---|